Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.6
-51.21%
20%
—
20.74%
20%
—
5 Years
Score2.6
Net Growth-51.21%
Net Trend20%
Net Income Consistency—
Rev Growth20.74%
Rev Trend20%
Revenue Consistency—
Eagle Pharmaceuticals Inc fundamental performance
Between 2017 and 2022, revenue grew from $ 236M to $ 316M and net income declined from $ 51M to $ 35M. Revenue increased in 1 of those 5 years; net income in 1.
Across Eagle Pharmaceuticals Inc's full reported history, from 2014 to 2022, revenue grew from $ 19M to $ 316M and net income went from -$ 17M to $ 35M. Revenue increased in 44% of the years measured; net income in 33%.
Eagle Pharmaceuticals Inc currently holds a 5-year HDB Score of 2.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-11 | $ 0.10 | — |
1 Year2025-08-12 | $ 3.20 | -96.72% |
5 Years2021-08-12 | $ 47.74 | -99.78% |
10 Years2016-08-12 | $ 62.05 | -99.83% |
All Time2014-02-12 | $ 12.83 | -99.18% |
| Period | Last Price2026-08-11 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2014-02-12 |
|---|---|---|---|---|---|
| Price | $ 0.10 | $ 3.20 | $ 47.74 | $ 62.05 | $ 12.83 |
| Return | — | -96.72% | -99.78% | -99.83% | -99.18% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2023 | $ 257M | $ 15M | $ 15M |
| 2022 | $ 316M | $ 35M | $ 55M |
| 2021 | $ 171M | -$ 8M | $ 97M |
| 2020 | $ 187M | $ 11M | $ 103M |
| 2019 | $ 195M | $ 14M | $ 109M |
| 2018 | $ 213M | $ 31M | $ 78M |
| 2017 | $ 236M | $ 51M | $ 114M |
| 2016 | $ 189M | $ 81M | $ 52M |
| 2015 | $ 66M | $ 2M | $ 79M |
| IPO2014 | $ 19M | -$ 17M | $ 42M |
Explore beyond EGRX
You're looking at Eagle Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
